News and Announcements
Outstanding drill holes at Oropesa Project intersect significant high-grade tin mineralisation
- Published March 31, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Click here to view the ASX announcement.
About Elementos (ASX: ELT)
Listed on the ASX in 2009, Elementos Ltd has a long tradition of management excellence, locating high grade tin projects and in leading progressive thinking about tin as a positive, yet little known resource.
Like any ethical mining company, Elementos Ltd is committed to the safe and environmentally-conscious exploration, production and transport of tin resources, regardless of where it operates in the world.
Led by an experience-heavy management team and Board, Elementos is positioned as a diversified tin platform, with an ability to develop exciting projects in multiple countries.
Elementos is well-positioned to help bridge the significant shortfall in tin supply in the coming years. This shortfall is being partly driven by increasing global interest in renewable energy and electric vehicles.
Currently tin stocks are near historic lows, and these are predicted to fall below the two weeks supply/consumption ratio.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
